OCT4 induces the transcription of miR-18a, which targets multiple tumor suppressors, enhances PI3K/AKT, MEK/ERK, and Wnt/β-catenin pathway activity, and attenuates p53 signaling, finally leading to PD-L1 upregulation (Fig. 5). This evidence concerns the gene TP53 and neoplasm.